|

GM-CSF Clinical Trials

8 actively recruiting trials across 4 locations

▲ +2 trials since May 2026

Also known as: Granulocyte-Macrophage Colony-Stimulating Factor, Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor, Sargramostim, granulocyte-macrophage colony-stimulating factor, sargramostim

Pipeline

Phase 1: 4Phase 2: 4

Top Sponsors

  • David Avigan3
  • Sun Yat-sen University1
  • Sun Yat-Sen University Cancer Center1
  • New Approaches to Neuroblastoma Therapy Consortium1
  • Memorial Sloan Kettering Cancer Center1

Indications

  • Cancer8
  • Neuroblastoma3
  • Relapse Multiple Myeloma2
  • Refractory Multiple Myeloma2
  • Multiple Myeloma2

Boston, Massachusetts3 trials

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Beth Israel Deaconess Medical Center

Phase 1
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Beth Israel Deaconess Medical Center

Phase 1
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

Beth Israel Deaconess Medical Center

Phase 1

Other2 trials

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Phase 2
The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy
Phase 2

Los Angeles, California1 trial

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Children's Hospital Los Angeles

Phase 2

New York, New York1 trial

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2

Milwaukee, Wisconsin1 trial

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Froedtert & the Medical College of Wisconsin

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.